Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
accelerate, accessibility, accommodate, acquisition, adapt, Additionally, Aid, approach, arise, arising, arose, arrangement, assembled, assistance, automatic, back, billion, branded, breakout, buying, campaign, CAPLYTA, CAPLYTATM, CAPYLTA, care, chain, channel, Chargeback, China, claim, claimed, clause, collateral, commitment, commonly, constrained, constraint, consummation, contemplated, costly, coverage, create, customer, cyber, dedicated, degree, delivery, detailed, direct, disposal, disrupt, distinct, diversion, enable, encounter, equivalent, Europe, evolve, evolving, expensesbetween, explicitly, FIFO, fix, fleet, forecasted, gap, glitch, handling, health, healthcare, home, inclusive, increasingly, Inducement, industry, inlate, insignificant, instructed, instrument, Interpretation, invoiced, irrevocable, iv, led, Lessor, letter, line, list, Listing, local, loosen, Mach, magnitude, mandated, marked, Medicaid, Medicare, merit, mix, negatively, negotiated, newly, NOL, nonlumateperone, notice, notification, obsolete, ofc, ofITI, onboarding, opposed, organization, outbreak, overhaul, owe, pandemic, path, payer, payroll, percent, pharmacy, point, post, preparatory, promised, promising, promotion, promotional, prompt, properly, rapidly, receipt, reclassified, reconciliation, Relief, rely, remitted, remitting, renewal, rental, resale, resell, respond, retail, retention, Russia, seasoned, seeProduct, shipment, shipping, sNDA, specialty, stipulated, stockholder, strain, sum, supplemental, supply, surfaced, team, technical, TRAC, travel, unexpected, unlimited, ur, variable, vehicle, vehiclesat, virtually, visibility, voluntary, voucher, wholesale, wholesaler, workforce, written, Wuhan
Removed:
acute, affinity, agonist, amend, antagonism, antagonist, antidepressant, antipsychotic, array, assigned, attained, avoiding, blockade, brain, broad, clinically, collectability, collecting, collection, combined, comparability, consistency, core, counterparty, decline, deductibility, deficit, Delaware, designation, disaggregate, discontinue, distinguishing, DMC, dopamine, dopaminergic, doubtful, DPPM, dual, duration, executing, exercised, expedient, expensing, expose, Fast, FDIC, final, finance, formed, forward, futility, glutamate, glutamatergic, higher, hindsight, hire, history, impaired, improved, improving, independent, inhibition, intent, interim, International, leading, MDD, mechanism, mediate, medicine, merger, mesolimbic, migration, modified, modulation, monitoring, neurologic, NMDA, Oneida, outdated, outlook, overlapping, partial, passing, PDUFA, permitted, phosphoprotein, phosphorylation, potent, precommercial, prepare, presentation, President, principle, prospective, psychosocial, receptor, reclassification, recommended, recovery, redundant, regular, release, repealed, residual, restate, retained, retrospective, retrospectively, reuptake, reverse, robust, rolling, schizoaffective, scoping, selectivity, serotonergic, serotonin, shell, side, Simplification, spending, stimulate, stopped, stranded, superseded, supported, target, taxation, territorial, therapeutic, thought, tolerated, Track, transition, treated, Trump, uncollectible, User, wake
Filing tables
Filing exhibits
Associated ITCI transcripts
ITCI similar filings
Filing view
External links
Exhibit 32
CERTIFICATIONS UNDER SECTION 906
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Intra-Cellular Therapies, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Quarterly Report for the quarter ended March 31, 2020 (the “Form10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in theForm 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: May 7, 2020 | /s/ Sharon Mates, Ph.D. | |||||
Sharon Mates, Ph.D. | ||||||
Chairman, President and Chief Executive Officer | ||||||
(principal executive officer) | ||||||
Dated: May 7, 2020 | /s/ Lawrence J. Hineline | |||||
Lawrence J. Hineline | ||||||
Senior Vice President of Finance and Chief Financial Officer | ||||||
(principal financial officer) |